An inulin and doxorubicin conjugate for improving cancer therapy.
about
Gut microbiota modulation of chemotherapy efficacy and toxicity.pH-responsive hydrogels containing PMMA nanoparticles: an analysis of controlled release of a chemotherapeutic conjugate and transport properties.Anticancer effects of the microbiome and its products.Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies.
P2860
An inulin and doxorubicin conjugate for improving cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
An inulin and doxorubicin conjugate for improving cancer therapy.
@en
An inulin and doxorubicin conjugate for improving cancer therapy.
@nl
type
label
An inulin and doxorubicin conjugate for improving cancer therapy.
@en
An inulin and doxorubicin conjugate for improving cancer therapy.
@nl
prefLabel
An inulin and doxorubicin conjugate for improving cancer therapy.
@en
An inulin and doxorubicin conjugate for improving cancer therapy.
@nl
P2093
P2860
P1476
An inulin and doxorubicin conjugate for improving cancer therapy.
@en
P2093
B Carillo-Conde
C A Schoener
H N Hutson
N A Peppas
P2860
P304
P356
10.1016/S1773-2247(13)50018-9
P577
2013-01-01T00:00:00Z